Melanotan II

Also known as: MT-2, Melanotan 2

Overview

Tanning and sexual dysfunction (research)

Melanotan II is a synthetic analog of alpha-melanocyte stimulating hormone that binds to melanocortin receptors. Originally developed for skin tanning protection against UV damage, it was found to have significant effects on sexual arousal and erectile function. Development was discontinued due to side effects and regulatory concerns. It is not FDA-approved.

Mechanism of Action

Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on sexual arousal

Dosage Information

Parameter	Detail
Administration	Subcutaneous injection
Typical Dose	0.25-1mg 2-3x per week
Frequency	As needed

Side Effects

Reported adverse effects from clinical data and post-market surveillance

Common Side Effects

Nausea

Flushing

Spontaneous erections

Darkening of moles and freckles

Yawning

Serious Side Effects

New mole formation

Changes in existing moles

Cardiovascular effects

Unknown cancer risk

!Contraindications

Do not use this peptide if any of the following apply

Pregnancy
Personal or family history of melanoma
Cardiovascular disease
Children

Clinical Evidence

Evidence Quality

Low / Preclinical

Clinical Trial Phase

Preclinical / Not submitted

View Key Study

Cost Comparison

Estimated monthly costs compared to similar peptides

Peptide	Monthly Cost	FDA Status
Melanotan II	$30 - $60/mo	Not submitted
PT-141	$800 - $1200/mo	FDA Approved

Medical Disclaimer

The information provided on this page is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy or medication. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary.